|
MechanismPOLA1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date28 Oct 2005 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date09 Jan 1979 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date09 Mar 1959 |
100 Clinical Results associated with Reach Pharmaceuticals Pty Ltd.
0 Patents (Medical) associated with Reach Pharmaceuticals Pty Ltd.
100 Deals associated with Reach Pharmaceuticals Pty Ltd.
100 Translational Medicine associated with Reach Pharmaceuticals Pty Ltd.